Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' SOBEL BE' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 163 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Sobel, BE; Levine, MA
      Medical education, evidence-based medicine, and the disqualification of physician-scientists

      EXPERIMENTAL BIOLOGY AND MEDICINE
    2. Li, MY; Absher, PM; Liang, P; Russell, JC; Sobel, BE; Fukagawa, NK
      High glucose concentrations induce oxidative damage to mitochondrial DNA in explanted vascular smooth muscle cells

      EXPERIMENTAL BIOLOGY AND MEDICINE
    3. Sobel, BE
      HEART Group notification regarding 'management of potential conflict of interest'

      CORONARY ARTERY DISEASE
    4. Sobel, BE
      Fibrin specificity of plasminogen activators, rebound generation of thrombin, and their therapeutic implications

      CORONARY ARTERY DISEASE
    5. Levine, RA; Sobel, BE
      Insulinoma, type 2 diabetes and plasminogen activator inhibitor type-I

      CORONARY ARTERY DISEASE
    6. Holmes, MB; Kabbani, SS; Terrien, CM; Watkins, MW; Sobel, BE; Schneider, DJ
      Quantification by flow cytometry of the efficacy of and interindividual variation of platelet inhibition induced by treatment with tirofiban and abciximab

      CORONARY ARTERY DISEASE
    7. Kabbani, SS; Watkins, MW; Holoch, PA; Terrien, EF; Sobel, BE; Schneider, DJ
      Platelet reactivity in coronary ostial blood: A reflection of the thrombotic state accompanying plaque rupture and of the adequacy of anti-thrombotictherapy

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    8. Nordt, TK; Lutzi, S; Ruef, J; Peter, K; Klar, E; Kubler, W; Sobel, BE; Bode, C
      Attenuation by fibrates of plasminogen activator inhibitor type-1 expression in human arterial smooth muscle cells

      THROMBOSIS AND HAEMOSTASIS
    9. Schneider, DJ; Baumann, PQ; Holmes, MB; Taatjes, DJ; Sobel, BE
      Time and dose dependent augmentation of inhibitory effects of abciximab byaspirin

      THROMBOSIS AND HAEMOSTASIS
    10. Nordt, TK; Bode, C; Sobel, BE
      Stimulation in vivo of expression of intra-abdominal adipose tissue plasminogen activator inhibitor Type I by proinsulin

      DIABETOLOGIA
    11. Baran, KW; Nguyen, M; McKendall, GR; Lambrew, CT; Dykstra, G; Palmeri, ST; Gibbons, RJ; Borzak, S; Sobel, BE; Gourlay, SG; Rundle, AC; Gibson, CM; Barron, HV
      Double-blind, randomized trial of an Anti-CD18 antibody in conjunction with recombinant tissue plasminogen activator for acute myocardial infarction - Limitation of myocardial infarction following thrombolysis in acute myocardial infarction (LIMIT AMI) study

      CIRCULATION
    12. Kabbani, SS; Watkins, MW; Ashikaga, T; Terrien, EF; Holoch, PA; Sobel, BE; Schneider, DJ
      Platelet reactivity characterized prospectively - A determinant of outcome90 days after percutaneous coronary intervention

      CIRCULATION
    13. Sobel, BE
      Acceleration of restenosis by diabetes - Pathogenetic implications

      CIRCULATION
    14. Zaman, AKMT; Fujii, S; Sawa, H; Goto, D; Ishimori, N; Watano, K; Kaneko, T; Furumoto, T; Sugawara, T; Sakuma, I; Kitabatake, A; Sobel, BE
      Angiotensin-converting enzyme inhibition attenuates hypofibrinolysis and reduces cardiac perivascular fibrosis in genetically obese diabetic

      CIRCULATION
    15. Schneider, DJ; Sobel, BE
      Plaque vulnerability and acute coronary syndromes: what are the prophylactic and therapeutic implications?

      CHALLENGES IN ACUTE CORONARY SYNDROMES
    16. Schneider, DJ; Sobel, BE
      Diabetes and thrombosis

      DIABETES AND CARDIOVASCULAR DISEASE
    17. Binbrek, A; Rao, N; Absher, PM; Van de Werf, F; Sobel, BE
      The relative rapidity of recanalization induced by recombinant tissue-typeplasminogen activator (r-tPA) and TNK-tPA, assessed with enzymatic methods

      CORONARY ARTERY DISEASE
    18. Sobel, BE
      In memoriam: Francis X. Witkowski

      CORONARY ARTERY DISEASE
    19. Taatjes, DJ; Wadsworth, MP; Schneider, DJ; Sobel, BE
      Improved quantitative characterization of atherosclerotic plaque composition with immunohistochemistry, confocal fluorescence microscopy, and computer-assisted image analysis

      HISTOCHEMISTRY AND CELL BIOLOGY
    20. Sobel, BE; LeWinter, MM
      Ingenuous interpretation of elevated blood levels of macromolecular markers of myocardial injury: A recipe for confusion

      JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    21. Nordt, TK; Peter, K; Bode, C; Sobel, BE
      Differential regulation by troglitazone of plasminogen activator inhibitortype 1 in human hepatic and vascular cells

      JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    22. Kruszynska, YT; Yu, JG; Olefsky, JM; Sobel, BE
      Effects of troglitazone on blood concentrations of plasminogen activator inhibitor 1 in patients with type 2 diabetes and in lean and obese normal subjects

      DIABETES
    23. Holmes, MB; Schneider, DJ; Hayes, MG; Sobel, BE; Mann, KG
      Novel, bedside, tissue factor-dependent clotting assay permits improved assessment of combination antithrombotic and antiplatelet therapy

      CIRCULATION
    24. Schneider, DJ; Taatjes, DJ; Sobel, BE
      Paradoxical inhibition of fibrinogen binding and potentiation of alpha-granule release by specific types of inhibitors of glycoprotein IIb-IIIa

      CARDIOVASCULAR RESEARCH
    25. Kjekshus, JK; Maroko, PR; Sobel, BE
      Distribution of myocardial injury and its relation to epicardial ST-segment changes after coronary artery occlusion in the dog

      CARDIOVASCULAR RESEARCH
    26. Hopkins, WE; Fukagawa, NK; Sobel, BE; Schneider, DJ
      Plasminogen activator inhibitor type 1 in adults with Down syndrome and protection against macrovascular disease

      AMERICAN JOURNAL OF CARDIOLOGY
    27. Holmes, MB; Sobel, BE; Cannon, CP; Schneider, DJ
      Increased platelet reactivity in patients given Orbofiban after an acute coronary syndrome: An OPUS-TIMI 16 substudy

      AMERICAN JOURNAL OF CARDIOLOGY
    28. Ginsberg, H; Plutzky, J; Sobel, BE
      A review of metabolic and cardiovascular effects of oral antidiabetic agents: beyond glucose-level lowering

      JOURNAL OF CARDIOVASCULAR RISK
    29. Sobel, BE
      The potential influence of insulin and plasminogen activator inhibitor type 1 on the formation of vulnerable atherosclerotic plaques associated with type 2 diabetes

      PROCEEDINGS OF THE ASSOCIATION OF AMERICAN PHYSICIANS
    30. Okada, H; Shatos, MA; Doherty, JM; Sobel, BE; Fujii, S
      Biochemical properties potentially rendering human brain microvasculature vulnerable to proteolytic injury associated with the use of fibrinolytic drugs

      CORONARY ARTERY DISEASE
    31. Absher, PM; Hendley, E; Jaworski, DM; Taatjes, DJ; Sobel, BE
      Impairment of the blood-brain barrier: a potential surrogate delineating the determinants of cerebral bleeding caused by fibrinolytic drugs

      CORONARY ARTERY DISEASE
    32. Sobel, BE
      Biomarkers, surrogates, and evaluation of therapeutic agents: a proposed solution

      CORONARY ARTERY DISEASE
    33. Fukagawa, NK; Li, MY; Liang, P; Russell, JC; Sobel, BE; Absher, PM
      Aging and high concentrations of glucose potentiate injury to mitochondrial DNA

      FREE RADICAL BIOLOGY AND MEDICINE
    34. Amowitz, LL; Sobel, BE
      Cardiovascular consequences of polycystic ovary syndrome

      ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
    35. Sobel, BE
      The language of lysis: A proposal to standardize the nomenclature

      JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    36. Schneider, DJ; Taatjes, DJ; Howard, DB; Sobel, BE
      Increased reactivity of platelets induced by fibrinogen independent of itsbinding to the IIb-IIIa surface glycoprotein: A potential contributor to cardiovascular risk

      JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    37. Sakamoto, T; Woodcock-Mitchell, J; Marutsuka, K; Mitchell, JJ; Sobel, BE; Fujii, S
      TNF-alpha and insulin, alone and synergistically, induce plasminogen activator inhibitor-1 expression in adipocytes

      AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
    38. Holmes, MB; Sobel, BE; Howard, DB; Schneider, DJ
      Differences between activation thresholds for platelet P-selectin and glycoprotein IIb-IIIa expression and their clinical implications

      THROMBOSIS RESEARCH
    39. Absher, PM; Schneider, DJ; Baldor, LC; Russell, JC; Sobel, BE
      The retardation of vasculopathy induced by attenuation of insulin resistance in the corpulent JCR : LA-cp rat is reflected by decreased vascular smooth muscle cell proliferation in vivo

      ATHEROSCLEROSIS
    40. Sobel, BE
      Increased plasminogen activator inhibitor-1 and vasculopathy - A reconcilable paradox

      CIRCULATION
    41. Holmes, MB; Sobel, BE; Schneider, DJ
      Variable responses to inhibition of fibrinogen binding induced by Tirofiban and Eptifibatide in blood from healthy subjects

      AMERICAN JOURNAL OF CARDIOLOGY
    42. Sobel, BE
      Insulin resistance and thrombosis: A cardiologist's view

      AMERICAN JOURNAL OF CARDIOLOGY
    43. Farrell, TP; Hayes, KB; Sobel, BE; Schneider, DJ
      The lack of augmentation by aspirin of inhibition of platelet reactivity by Ticlopidine

      AMERICAN JOURNAL OF CARDIOLOGY
    44. Roberts, WC; Sobel, BE
      Burton Elias Sobel, MD: A conversation with the editor

      AMERICAN JOURNAL OF CARDIOLOGY
    45. SCHNEIDER DJ; TRACY PB; SOBEL BE
      ACUTE CORONARY SYNDROMES - 2 - ANTIPLATELET AGENTS

      Hospital practice
    46. SCHNEIDER DJ; TRACY PB; SOBEL BE
      ACUTE CORONARY SYNDROMES - 1 - THE PLATELETS ROLE

      Hospital practice
    47. MARUTSUKA K; WOODCOCKMITCHELL J; SAKAMOTO T; SOBEL BE; FUJII S
      PATHOGENETIC IMPLICATIONS OF HYALURONAN-INDUCED MODIFICATION OF VASCULAR SMOOTH-MUSCLE CELL FIBRINOLYSIS IN DIABETES

      Coronary artery disease
    48. SHEARD NF; NELSON HK; SOBEL BE
      DECREASING LONGCHAIN ACYLCARNITINE CONCENTRATION REDUCES THE INCIDENCE OF VENTRICULAR-FIBRILLATION FOLLOWING ISCHEMIA

      The FASEB journal
    49. FUKAGAWA NK; LI MY; LIANG P; SOBEL BE; ABSHER PM
      GLUCOSE-ASSOCIATED MITOCHONDRIAL-DNA (MTDNA) INJURY IN VASCULAR SMOOTH-MUSCLE CELLS (VSMC)

      Free radical biology & medicine
    50. SAKAMOTO T; WOODCOCKMITCHELL J; MARUTSUKA K; MITCHELL JJ; SOBEL BE; FUJII S
      TUMOR-NECROSIS-FACTOR-ALPHA AND INSULIN INDUCE PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 IN ADIPOCYTES

      Journal of the American College of Cardiology
    51. MARUTSUKA K; WOODCOCKMITCHELL J; SAKAMOTO T; SOBEL BE; FUJII S
      HYALURONAN-INDUCED MODIFICATION OF HUMAN AORTIC SMOOTH-MUSCLE CELL EXPRESSION OF FIBRINOLYTIC SYSTEM PROTEINS AND ITS IMPLICATIONS FOR VASCULOPATHY IN DIABETICS

      Journal of the American College of Cardiology
    52. CALLESESCANDON J; MIRZA S; SOBEL BE; SCHNEIDER DJ
      ELEVATION OF PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 (PAI-1) IN NORMALSUBJECTS BY INDUCTION OF HYPERINSULINEMIA WITH HYPERGLYCEMIA AND HYPERTRIGLYCERIDEMIA

      Journal of the American College of Cardiology
    53. FARRELL TP; HAYES KA; TRACY PB; SOBEL BE; SCHNEIDER DJ
      UNEXPECTED, DISCORDANT EFFECTS OF ASPIRIN ON PLATELET REACTIVITY

      Journal of the American College of Cardiology
    54. SAKAMOTO T; WOODCOCKMITCHELL J; MARUTSUKA K; SOBEL BE; FUJII S
      LOVASTATIN INHIBITS PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 PRODUCTIONBY ADIPOCYTES

      Journal of the American College of Cardiology
    55. WATKINS MW; LUETMER PA; SCHNEIDER DJ; WITMER WT; VAITKUS PT; SOBEL BE
      DETERMINANTS OF REBOUND THROMBIN ACTIVITY AFTER CESSATION OF HEPARIN IN PATIENTS UNDERGOING CORONARY INTERVENTIONS

      Catheterization and cardiovascular diagnosis
    56. NORDT TK; SAWA H; FUJII S; BODE C; SOBEL BE
      AUGMENTATION OF ARTERIAL ENDOTHELIAL-CELL EXPRESSION OF THE PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 (PAI-1) GENE BY PROINSULIN AND INSULIN IN-VIVO

      Journal of Molecular and Cellular Cardiology
    57. SCHNEIDER DJ; ABSHER PM; NEIMANE D; RUSSELL JC; SOBEL BE
      FIBRINOLYSIS AND ATHEROGENESIS IN THE JCR-LA-CP RAT IN RELATION TO INSULIN AND TRIGLYCERIDE CONCENTRATIONS IN BLOOD

      Diabetologia
    58. CALLESESCANDON J; MIRZA SA; SOBEL BE; SCHNEIDER DJ
      INDUCTION OF HYPERINSULINEMIA COMBINED WITH HYPERGLYCEMIA AND HYPERTRIGLYCERIDEMIA INCREASES PLASMINOGEN-ACTIVATOR INHIBITOR-1 IN BLOOD IN NORMAL HUMAN-SUBJECTS

      Diabetes
    59. GOTO D; ZAMAN TAKM; SAKUMA I; GAO M; KOYAMA T; WOODCOCKMITCHELL J; MITCHELL J; SOBEL BE; FUJII S
      CORONARY ANGIOGENESIS IN RESPONSE TO L-NAME - GROWTH-CHARACTERISTICS AND UP-REGULATION OF BASIC FIBROBLAST-GROWTH-FACTOR

      Circulation
    60. ISHIMORI N; WATANO K; GOTO D; KANEKO T; MAKIGUCHI M; TAKATSUJI H; NAKAGAWA T; MITCHELL J; WOODCOCKMITCHELL J; SOBEL BE; FUJII S; KITABATAKE A
      HYPERINSULINEMIA AND SUBSEQUENT IMPAIRED FIBRINOLYSIS DETERMINE THE SEVERITY OF CORONARY-ARTERY DISEASE IN OBESE SUBJECTS

      Circulation
    61. SOBEL BE; WOODCOCKMITCHELL J; SCHNEIDER DJ; HOLT RE; MARUTSUKA K; GOLD H
      INCREASED PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 IN CORONARY-ARTERY ATHERECTOMY SPECIMENS FROM TYPE-2 DIABETIC COMPARED WITH NONDIABETIC PATIENTS - A POTENTIAL FACTOR PREDISPOSING TO THROMBOSIS AND ITS PERSISTENCE

      Circulation
    62. OKADA H; WOODCOCKMITCHELL J; MITCHELL J; SAKAMOTO T; MARUTSUKA K; SOBEL BE; FUJII S
      INDUCTION OF PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 AND TYPE-1 COLLAGEN EXPRESSION IN RAT CARDIAC MICROVASCULAR ENDOTHELIAL-CELLS BY INTERLEUKIN-1 AND ITS DEPENDENCE ON OXYGEN-CENTERED FREE-RADICALS

      Circulation
    63. SOBEL BE
      INTERPRETATION OF RESULTS OF CLINICAL-TRIALS IN CORONARY THROMBOLYSIS

      Fibrinolysis & proteolysis
    64. NORDT TK; SAWA H; FUJII S; SOBEL BE
      HYPERINSULINEMIA INCREASES PLASMA ACTIVITY OF PAI-1 IN-VIVO INDEPENDENTLY OF ACUTE-PHASE REACTION

      Fibrinolysis & proteolysis
    65. SCHNEIDER DJ; RICCI MA; TAATJES DJ; BAUMANN PQ; REESE JC; LEAVITT BJ; ABSHER PM; SOBEL BE
      CHANGES IN ARTERIAL EXPRESSION OF FIBRINOLYTIC SYSTEM PROTEINS IN ATHEROGENESIS

      Arteriosclerosis, thrombosis, and vascular biology
    66. SOBEL BE
      HOW DOES THE COAGULATION SYSTEM REALLY WORK AND WHY SHOULD WE CARE

      Coronary artery disease
    67. GALBRAITH RA; SOBEL BE
      PATIENT INFORMATION AND CONFIDENTIALITY - A COMPELLING CONUNDRUM

      Coronary artery disease
    68. SOBEL BE
      HEPARIN AND STREPTOKINASE

      Cardiovascular drugs and therapy
    69. SCHNEIDER DJ; ABSHER PM; RUSSELL JC; SOBEL BE
      INCREASED EXPRESSION OF PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 (PAI-1) PREDISPOSES TO ATHEROSCLEROSIS IN CORPULENT, INSULIN-RESISTANT (JCR-LA-CP) RATS THAT MIMIC DERANGEMENTS IN TYPE-II DIABETES

      Journal of the American College of Cardiology
    70. SAKAMOTO T; WOODCOCKMITCHELL J; MARUTSUKA K; SOBEL BE; FUJII S
      TUMOR-NECROSIS-FACTOR-ALPHA AND INSULIN INCREASE PLASMINOGEN-ACTIVATOR INHIBITOR-1 PRODUCTION IN ADIPOCYTES

      Journal of the American College of Cardiology
    71. SCHNEIDER DJ; SOBEL BE
      SYNERGISTIC AUGMENTATION OF EXPRESSION OF PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-I (PAI-1) IN HUMAN HEPATOMA (HEPG2) CELLS BY INSULIN AND FATTY-ACIDS

      Journal of the American College of Cardiology
    72. TAATJES DJ; WADSWORTH M; ABSHER PM; SOBEL BE; SCHNEIDER DJ
      IMMUNOELECTRON MICROSCOPIC LOCALIZATION OF PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 (PAI-1) IN SMOOTH-MUSCLE CELLS FROM MORPHOLOGICALLY NORMAL AND ATHEROSCLEROTIC HUMAN ARTERIES

      Ultrastructural pathology
    73. SCHNEIDER DJ; SOBEL BE
      DETERMINANTS OF CORONARY VASCULAR-DISEASE IN PATIENTS WITH TYPE-II DIABETES-MELLITUS AND THEIR THERAPEUTIC IMPLICATIONS

      Clinical cardiology
    74. EHRMANN DA; SCHNEIDER DJ; SOBEL BE; CAVAGHAN MK; IMPERIAL J; ROSENFIELD RL; POLONSKY KS
      TROGLITAZONE IMPROVES DEFECTS IN INSULIN ACTION, INSULIN-SECRETION, OVARIAN STEROIDOGENESIS, AND FIBRINOLYSIS IN WOMEN WITH POLYCYSTIC-OVARY-SYNDROME

      The Journal of clinical endocrinology and metabolism
    75. ABSHER PM; SCHNEIDER DJ; BALDOR LC; RUSSELL JC; SOBEL BE
      INCREASED PROLIFERATION OF EXPLANTED VASCULAR SMOOTH-MUSCLE CELLS - AMARKER PRESAGING ATHEROGENESIS

      Atherosclerosis
    76. SCHNEIDER DJ; TRACY PB; MANN KG; SOBEL BE
      DIFFERENTIAL-EFFECTS OF ANTICOAGULANTS ON THE ACTIVATION OF PLATELETSEX-VIVO

      Circulation
    77. SAKAMOTO T; WOODCOCKMITCHELL J; MARUTSUKA K; SOBEL BE; FUJI S
      SYNERGISTIC AUGMENTATION OF EXPRESSION OF PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 BY INSULIN AND TNF-ALPHA IN ADIPOCYTES - A POTENTIAL LINK BETWEEN VASCULOPATHY AND THE INSULIN-RESISTANCE TYPICAL OF OBESITY

      Circulation
    78. SAKAMOTO T; WOODCOCKMITCHELL J; FUJI S; SOBEL BE; SCHNEIDER DJ
      AUGMENTATION OF EXPRESSION OF PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 IN ADIPOCYTES AND ITS POTENTIAL ROLE IN ACCELERATION OF VASCULOPATHY ASSOCIATED WITH OBESITY

      Circulation
    79. NORDT T; LUTZI S; PETER K; SOBEL BE; BODE C
      ATTENUATION BY GEMFIBROZIL OF PAI-1 EXPRESSION INDUCED BY TGF-BETA INHUMAN AORTIC SMOOTH-MUSCLE CELLS

      Circulation
    80. WOODCOCKMITCHELL J; MARUTSUKA K; HOLT RE; GOLD HK; SOBEL BE
      DIFFERENTIAL EXPRESSION OF FIBRINOLYTIC SYSTEM PROTEINS IN CORONARY ATHEROMA FROM TYPE-II DIABETIC AND NON DIABETIC SUBJECTS

      Circulation
    81. ABSHER PM; SCHNEIDER DJ; RUSSELL JC; SOBEL BE
      INSULIN-INDUCED PROLIFERATION OF VASCULAR SMOOTH-MUSCLE CELLS IN-VITRO AND IN-VIVO - A PROGENITOR OF ATHEROSCLEROSIS

      Circulation
    82. SOBEL BE; FURBERG CD
      SURROGATES, SEMANTICS, AND SENSIBLE PUBLIC-POLICY

      Circulation
    83. NORDT TK; KORNAS K; PETER K; FUJII S; SOBEL BE; KUBLER W; BODE C
      ATTENUATION BY GEMFIBROZIL OF EXPRESSION OF PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 INDUCED BY INSULIN AND ITS PRECURSORS

      Circulation
    84. CANNON CP; MCCABE CH; GIBSON CM; GHALI M; SEQUEIRA RF; MCKENDALL GR; BREED J; MODI NB; FOX NL; TRACY RP; LOVE TW; BRAUNWALD E; COULSON T; MAYOR MR; GIRWARR G; TEIXEIRO P; WILLIAMS DO; MCDONALD M; KIRSHENBAUM JM; CLOUTIER J; HENRY TD; KNOX L; BOISJOLIE C; SCHWEIGER MJ; BURKOTT B; WARWICK D; CARNEY R; MURPHY G; CUTLER D; MALMBERG G; GREENE RM; HEALY E; PERRY V; WATKINS M; SOBEL BE; ROWEN M; WILSON W; CUTTITTA J; NIEDERMAN A; KELLERMAN T; FREY M; TAYLOR H; MUELLER HS; KUNKEL L; COSICO J; CASALE P; TUZI J; ROGERS WJ; MORGAN T; ANDERSON JL; KARAGOUNIS L; ALLEN A; HOCHMAN JS; MCANULTY M
      TNK-TISSUE PLASMINOGEN-ACTIVATOR IN ACUTE MYOCARDIAL-INFARCTION - RESULTS OF THE THROMBOLYSIS IN MYOCARDIAL-INFARCTION (TIMI) 10A DOSE-RANGING TRIAL

      Circulation
    85. SOBEL BE; NORDT TK
      CLOT-SELECTIVE COMPARED WITH NONSELECTIVE FIBRINOLYTIC DRUGS - DEJA-VU - ALL OVER AGAIN

      Coronary artery disease
    86. SOBEL BE
      CONJUNCTIVE ANTICOAGULATION AND CORONARY THROMBOLYSIS

      Coronary artery disease
    87. SOBEL BE
      DOCTOR-ASSISTED SUICIDE - AN INSIDIOUS MALAPROPISM UNDERMINING TRUST

      Coronary artery disease
    88. SOBEL BE
      YES, MEAGHAN, THERE IS A

      Coronary artery disease
    89. SOBEL BE
      ANGIOPLASTY OR THROMBOLYSIS - MISCONSTRUED QUESTIONS AND MISLEADING ANSWERS

      Coronary artery disease
    90. SCHNEIDER DJ; SOBEL BE
      SYNERGISTIC AUGMENTATION OF EXPRESSION OF PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 INDUCED BY INSULIN, VERY-LOW-DENSITY LIPOPROTEINS, AND FATTY-ACIDS

      Coronary artery disease
    91. LUNDGREN C; SOBEL BE; FUJII S
      PERSISTENCE OF BALLOON-INDUCED ARTERIAL INJURY WITH HYPERLIPIDEMIA DESPITE GEMFIBROZIL

      Japanese Heart Journal
    92. ABSHER MP; SCHNEIDER DJ; RUSSELL JC; SOBEL BE
      INTRINSIC ABNORMALITIES IN VASCULAR SMOOTH-MUSCLE CELL-PROLIFERATION - POTENTIAL DETERMINANTS OF ATHEROSCLEROSIS INDUCED BY GENETICALLY-DETERMINED INSULIN-RESISTANCE IN RATS

      Circulation
    93. SAKUMA I; GAO M; HATTORI Y; SATO A; TAMADA A; AKAISHI Y; FUKAO M; KANNO M; KITABATAKE A; KOYAMA T; SOBEL BE; FUJII S
      INSULIN AND PROINSULIN REGULATE PLASMINOGEN-ACTIVATOR INHIBITOR-1 ANDTYPE-I COLLAGEN-SYNTHESIS IN CARDIAC MICROVASCULAR ENDOTHELIAL-CELLS - POTENTIAL ROLE IN DEVELOPMENT OF CORONARY MICROVASCULOPATHY

      Circulation
    94. WATKINS MW; LUETMER PA; WITMER WT; VAITKUS PT; SCHNEIDER DJ; SOBEL BE
      REBOUND GENERATION OF THROMBIN AFTER CORONARY INTERVENTIONS - A POTENTIAL CONTRIBUTOR TO SUBACUTE THROMBOSIS

      Circulation
    95. SHATOS MA; DOHERTY JM; PENAR PL; SOBEL BE
      SUPPRESSION OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 RELEASE FROM HUMAN CEREBRAL ENDOTHELIUM BY PLASMINOGEN ACTIVATORS - A FACTOR POTENTIALLY PREDISPOSING TO INTRACRANIAL BLEEDING

      Circulation
    96. SOBEL BE
      RESTENOSIS IN DIABETIC-PATIENTS - IS HYPERINSULINEMIA THE CULPRIT - REPLY

      Circulation
    97. SOBEL BE
      POTENTIATION OF VASCULOPATHY BY INSULIN - IMPLICATIONS FROM AN NHLBI CLINICAL ALERT

      Circulation
    98. LUNDGREN CH; BROWN SL; NORDT TK; SOBEL BE; FUJII S
      ELABORATION OF TYPE-1 PLASMINOGEN-ACTIVATOR INHIBITOR FROM ADIPOCYTES- A POTENTIAL PATHOGENETIC LINK BETWEEN OBESITY AND CARDIOVASCULAR-DISEASE

      Circulation
    99. NODAHEINY H; DAUGHERTY A; SOBEL BE
      AUGMENTED UROKINASE RECEPTOR EXPRESSION IN ATHEROMA

      Arteriosclerosis, thrombosis, and vascular biology
    100. DEBRUYN VH; BERGMANN SR; KEYT BA; BENNETT WF; SOBEL BE
      SCINTIGRAPHIC VISUALIZATION OF PULMONARY THROMBI WITH I-123 YPACK-TNK-TPA

      Coronary artery disease


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 25/10/20 alle ore 12:53:46